Nuvectis Pharma Inc (NVCT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $696.03M
Last updated: Nov 17, 2026 at 4:10 PM ET
Nuvectis Pharma Inc (NVCT) Stock Chart
Nuvectis Pharma (NVCT) has a latest price of $19.20 on Nov 17, 2026, 34.4% below its 52-week high of $29.27. Its price rose 218.9% over the past 12 months. The month-end price rose 106.5% over the 3 years through Oct 2026, a compound annual rate of 27.3%.
Price Chart
From Feb 2022 to Oct 2026, its highest month-end close was $22.73 in Aug 2026 and its lowest $5.04 in Nov 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NVCT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NVCT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 17.7%, and over 6 months it rose 86.4%.
| Period | Change |
|---|---|
| 1 month | +1.4% |
| 3 months | -17.7% |
| 6 months | +86.4% |
| 12 months | +218.9% |
| 12 months, with dividends | +218.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +106.5% | +27.3% |
Price by Year
Its best calendar year was 2025, when the price rose 39.6%, and its weakest was 2024, when it fell 35.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $18.48 | +144.8% |
| 2025 | $7.55 | +39.6% |
| 2024 | $5.41 | -35.1% |
| 2023 | $8.34 | +11.2% |
Trading Range
The price is 5.9% below its 50-day average of $20.40 and 25.6% above its 200-day average of $15.29.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $19.20 | |
| 52-week high | $29.27 | -34.4% |
| 52-week low | $5.77 | +232.8% |
| 50-day average | $20.40 | -5.9% |
| 200-day average | $15.29 | +25.6% |
Price Risk
Over 3 years, its largest fall from a peak was 58.9%.
| Measure | Value |
|---|---|
| 1-year beta | 0.81 |
| Largest fall, 1 year | -37.7% |
| Largest fall, 3 years | -58.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NVCT
What is NVCT's 1-year price change?
Nuvectis Pharma's price rose 218.9% over the past 12 months. With dividends included, the 12-month total return was 218.9%.
How has NVCT stock done over the long term?
Nuvectis Pharma's month-end price rose 106.5% over the 3 years through Oct 2026, a compound annual rate of 27.3%. These figures leave out dividends.
What is NVCT's 52-week high and low?
Nuvectis Pharma's 52-week high is $29.27 and its 52-week low is $5.77. Its latest price of $19.20 on Nov 17, 2026 is 34.4% below the high.
What is NVCT's beta?
Nuvectis Pharma's 1-year beta against the S&P 500 is 0.81, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 37.7%.
Is the NVCT chart free?
Yes. Advanced Charting for NVCT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NVCT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors